Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.036 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |